# Medtronic Cardiovascular clinical trials: 70 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 70 trials with Medtronic Cardiovascular as lead sponsor, 7 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Medtronic Cardiovascular: 70 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/medtronic-cardiovascular

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 70
- Recruiting or not yet: 7
- Read on: November 19, 2026

## Trials

The 25 newest of 70, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 10, 2026 | NCT07754318 | Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA) | Medtronic Cardiovascular | Not applicable | Recruiting | AAA - Abdominal Aortic Aneurysm | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754318) |
| January 7, 2026 | NCT07321899 | Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe... | Medtronic Cardiovascular | Not applicable | Recruiting | Severe Tricuspid Regurgitation | 1,186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07321899) |
| April 2, 2025 | NCT06906926 | Harmony TPV EMEA PMS | Medtronic Cardiovascular | Not applicable | Recruiting | Severe Pulmonary Valve Regurgitation | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06906926) |
| January 15, 2025 | NCT06777368 | REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE | Medtronic Cardiovascular | Observational | Recruiting | Aortic Stenosis | 225 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06777368) |
| August 11, 2022 | NCT05496998 | Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial | Medtronic Cardiovascular | Not applicable | Recruiting | Mitral Regurgitation | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05496998) |
| May 18, 2022 | NCT05378347 | Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial | Medtronic Cardiovascular | Not applicable | Recruiting | Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm \>= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm... | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05378347) |
| December 8, 2021 | NCT05149755 | Evolut™ EXPAND TAVR II Pivotal Trial | Medtronic Cardiovascular | Not applicable | Active not recruiting | Moderate Aortic Valve Stenosis | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05149755) |
| October 14, 2021 | NCT05077774 | Harmony TPV Post-Approval Study | Medtronic Cardiovascular | Not applicable | Active not recruiting | Congenital Heart Disease, Tetrology of Fallot, RVOT Anomaly, Pulmonary Regurgitation | 174 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05077774) |
| July 29, 2021 | NCT04982588 | Evolut PRO China Clinical Study | Medtronic Cardiovascular | Not applicable | Active not recruiting | Severe, Symptomatic Aortic Stenosis | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04982588) |
| January 25, 2021 | NCT04722250 | SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial | Medtronic Cardiovascular | Not applicable | Active not recruiting | Symptomatic Aortic Stenosis, Aortic Valve Stenosis, Aortic Valve Replacement | 1,103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04722250) |
| November 27, 2020 | NCT04645615 | European CURE-AF Study | Medtronic Cardiovascular | Not applicable | Completed | Atrial Fibrillation | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04645615) |
| November 20, 2020 | NCT04639258 | Medtronic Evolut™ EXPAND TAVR I Feasibility Study | Medtronic Cardiovascular | Not applicable | Terminated | Aortic Valve Stenosis | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04639258) |
| June 16, 2020 | NCT04433065 | TTVR Early Feasibility Study | Medtronic Cardiovascular | Not applicable | Active not recruiting | Tricuspid Regurgitation | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04433065) |
| February 12, 2020 | NCT04267055 | DISSECT-N Post Market Data Collection Registry | Medtronic Cardiovascular | Observational | Completed | Thoracic Aortic Dissection | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04267055) |
| September 16, 2019 | NCT04091048 | Optimize PRO Study | Medtronic Cardiovascular | Observational | Completed | Symptomatic Aortic Stenosis | 1,127 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04091048) |
| August 17, 2018 | NCT03635424 | Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study | Medtronic Cardiovascular | Not applicable | Active not recruiting | Bicuspid Aortic Valve | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03635424) |
| January 31, 2018 | NCT03417011 | FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System | Medtronic Cardiovascular | Observational | Completed | Aortic Valve Stenosis | 638 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03417011) |
| October 25, 2017 | NCT03320252 | Endurant CHevAr New Indication Trial: ENCHANT | Medtronic Cardiovascular | Observational | Active not recruiting | AAA - Abdominal Aortic Aneurysm | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03320252) |
| August 8, 2017 | NCT03242642 | Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. | Medtronic Cardiovascular | Not applicable | Recruiting | Mitral Valve Regurgitation | 1,056 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03242642) |
| May 3, 2016 | NCT02759237 | The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS) | Medtronic Cardiovascular | Observational | Terminated | Symptomatic Aortic Stenosis | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02759237) |
| April 21, 2016 | NCT02746809 | Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum) | Medtronic Cardiovascular | Not applicable | Completed | Aortic Valve Stenosis | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02746809) |
| April 14, 2016 | NCT02738853 | The Medtronic TAVR 2.0 US Clinical Study | Medtronic Cardiovascular | Not applicable | Completed | Aortic Valve Stenosis | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02738853) |
| March 8, 2016 | NCT02701283 | Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients | Medtronic Cardiovascular | Not applicable | Active not recruiting | Aortic Valve Stenosis | 2,223 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02701283) |
| January 12, 2016 | NCT02652949 | Valiant Evo US Clinical Trial | Medtronic Cardiovascular | Not applicable | Completed | Aortic Aneurysm, Thoracic | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02652949) |
| December 9, 2015 | NCT02625324 | Valiant Evo International Clinical Trial | Medtronic Cardiovascular | Not applicable | Completed | Aortic Aneurysm, Thoracic | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02625324) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 49 |
| Observational | 17 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 37 |
| Terminated | 14 |
| Active not recruiting | 10 |
| Recruiting | 7 |
| No longer available | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Aortic Valve Stenosis | 17 |
| Aortic Aneurysm, Abdominal | 17 |
| Aortic Aneurysm, Thoracic | 11 |
| Heart Valve Diseases | 10 |
| Mitral Valve Insufficiency | 4 |
| Aneurysm | 4 |
| Aortic Aneurysm | 4 |
| Atrial Fibrillation | 3 |
| Tricuspid Valve Insufficiency | 3 |
| Heart Defects, Congenital | 2 |
| Pulmonary Valve Insufficiency | 2 |
| Dissection, Thoracic Aorta | 2 |
| Aortic Diseases | 2 |
| Lymphoma, Follicular | 2 |
| Cardiovascular Diseases | 2 |
| Bicuspid Aortic Valve Disease | 1 |
| Tetralogy of Fallot | 1 |
| Penetrating Atherosclerotic Ulcer | 1 |
| Constriction, Pathologic | 1 |
| Aortic Dissection | 1 |
| Vascular Diseases | 1 |
| Aortic Valve Insufficiency | 1 |
| Heart Diseases | 1 |
| Gastroesophageal Reflux | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Public relations firms in the United States](https://specstream.ai/data/businesses/public-relations-firms/united-states)
- [Financial advisory firms in the United States](https://specstream.ai/data/businesses/financial-advisory-firms/united-states)
- [Window washing companies in the United States](https://specstream.ai/data/businesses/window-washing-companies/united-states)
- [Medical testing laboratories in the United States](https://specstream.ai/data/businesses/medical-testing-laboratories/united-states)
- [Clothing companies in the United States](https://specstream.ai/data/businesses/clothing-companies/united-states)
- [Siding contractors in the United States](https://specstream.ai/data/businesses/siding-contractors/united-states)
